DGX Quest Diagnostics Incorporated
USHealthcareAs of 2026-07-08 16:00
Why DGX matters now
Quest Diagnostics Incorporated (DGX) is a US stock in Healthcare. The latest InvestLog snapshot shows $208.21 with -1.96% on the session and $23.05B in market capitalization; recent performance reads 1-month +2.42% and YTD +12.37%.
The latest financial table shown here is Q1 2026, with revenue of $2.90B, net income of $252.0M, and EPS of $2.24. Investors can compare that operating picture with valuation signals such as P/E 21.37 and FCF yield 6.1%.
The latest indexable market news headline is "Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $220.00; recent insider activity includes KUPPUSAMY KARTHIK filing M-Exempt. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
21.37
PEG
1.54
P/B
2.91
P/S
1.91
EV/EBITDA
13.27
DCF Value
$223.04
FCF Yield
6.1%
Div Yield
1.7%
Margins & Returns
Gross Margin
33.2%
Operating Margin
14.3%
Net Margin
9.1%
ROE
14.1%
ROA
6.1%
ROIC
8.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.90B | $252.0M | $2.24 |
| Q4 2025 | $2.81B | $245.0M | $2.18 |
| FY 2025 | $11.04B | $992.0M | $8.75 |
| Q3 2025 | $2.82B | $245.0M | $2.16 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$220.57
Target (Median)
$220.00
Target Range
$210.00 - $235.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
0.59
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.